GKB Ophthalmics (BOM:533212) DeferredTaxAndRevenue: ₹0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:533212 GKB Ophthalmics Ltd BOM:533212
55 GF Score
Price ₹65.00
GF Value ₹164.28
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is GKB Ophthalmics DeferredTaxAndRevenue?

GKB Ophthalmics BOM:533212 +0.02% 55 DeferredTaxAndRevenue is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:533212 with a GF Score™ of 55/100 and a GF Value™ of ₹164.28 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

GKB Ophthalmics's current deferred tax and revenue for the quarter that ended in Mar. 2026 was ₹0 Mil.

GKB Ophthalmics DeferredTaxAndRevenue Related Terms

GKB Ophthalmics DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for GKB Ophthalmics's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GKB Ophthalmics DeferredTaxAndRevenue Chart

GKB Ophthalmics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GKB Ophthalmics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:533212
55GF Score
GKB Ophthalmics Ltd BOM:533212
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of ₹0 Mil mean?
GKB Ophthalmics (BOM:533212) has a DeferredTaxAndRevenue of ₹0 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on GKB Ophthalmics.
Is GKB Ophthalmics' DeferredTaxAndRevenue too high?
GKB Ophthalmics' current DeferredTaxAndRevenue is ₹0 Mil. Overall, GKB Ophthalmics has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GKB Ophthalmics' DeferredTaxAndRevenue compare to ISRG and BDX?
GKB Ophthalmics' DeferredTaxAndRevenue of ₹0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Medical Devices & Instruments company?
A good DeferredTaxAndRevenue depends on the Medical Devices & Instruments industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on GKB Ophthalmics. GKB Ophthalmics's current DeferredTaxAndRevenue is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GKB Ophthalmics stock overvalued right now?
Based on GuruFocus' analysis, GKB Ophthalmics (BOM:533212) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹164.28, compared to a current price of ₹65.00 — trading 60.4% below its estimated fair value. The current DeferredTaxAndRevenue is ₹0 Mil. GKB Ophthalmics' overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For GKB Ophthalmics (BOM:533212), the current DeferredTaxAndRevenue is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GKB Ophthalmics (BOM:533212) Overvalued in 2026?

Based on GuruFocus' analysis, GKB Ophthalmics stock appears to be undervalued. The current stock price of ₹65.00 is trading 60.4% below its estimated GF Value™ of ₹164.28. GuruFocus considers GKB Ophthalmics to be Significantly Undervalued.

Key valuation signals for BOM:533212:

  • DeferredTaxAndRevenue: ₹0 Mil
  • GF Value™: ₹164.28 vs. price of ₹65.00 (60.4% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the BOM:533212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GKB Ophthalmics Business Description

Address 16-A, Tivim Industrial Estate, Mapusa, GA, IND, 403 526
GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.
55GF Score

Get the complete analysis for BOM:533212

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹65.00
Price
₹164.28
GF Value